Neoplasms
|
0.100 |
Biomarker
|
group |
BEFREE |
CYP enzyme activity is differentially affected by the presence of tumour-associated inflammation, affecting particularly CYP2E1- and CYP3A-mediated drug metabolism, and may have profound implications for drug development and prescribing in oncological settings.
|
31236938 |
2019 |
Neoplasms
|
0.100 |
AlteredExpression
|
group |
BEFREE |
We finally obtained a list of only five genes (AGXT; ALDOB; CYP2E1; IGFBP3; TOP2A) that were differentially expressed in tumor and nontumor tissues across studies and were significantly correlated to HCC prognosis.Only AGXT had not been reported in HCC.
|
31771612 |
2019 |
Neoplasms
|
0.100 |
AlteredExpression
|
group |
BEFREE |
The results showed that the CYP2E1 constitutive activity was strongly correlated with tumor incidence and severity of liver tumorigenesis (nodule numbers and size), whereas inhibition of CYP2E1 activity decreased hepatocyte proliferation, liver injury, and liver carcinogenesis in the presence of DEN.
|
29467309 |
2018 |
Neoplasms
|
0.100 |
GeneticVariation
|
group |
BEFREE |
To investigate the independent roles of single nucleotide polymorphisms (SNPs) in base excision repair (BER) genes (APE1 and NEIL2), carcinogen metabolism gene (CYP2E1) and tumor suppressor pathway gene (MDM2) for gastric cancer susceptibility in a Chinese population, we conducted a hospital based case-control study to evaluate the potential association between these polymorphisms and susceptibility to gastric cancer in a Northern Jiangsu population.
|
26373042 |
2015 |
Neoplasms
|
0.100 |
GeneticVariation
|
group |
BEFREE |
CYP2E1 PstI polymorphism increases cervical neoplasia risk: a meta-analysis.
|
26125714 |
2015 |
Neoplasms
|
0.100 |
Biomarker
|
group |
BEFREE |
Intravenously injecting CYP2E1 recombinant adenovirus-loaded BMSCs in mice with established human melanoma managed to target the tumor site, and BMSCs with forced expression of CYP2E1 inhibited the growth of malignant cells in vivo by activating 5-(3,3-dimethyl-1-triazeno)imidazole-4-carboxamide.
|
24413391 |
2014 |
Neoplasms
|
0.100 |
GeneticVariation
|
group |
BEFREE |
The aim of this review is to outline the current knowledge on chemically-induced cancers through activation by CYP2E1, with emphasis on the association between polymorphisms of the CYP2E1 gene and incidence of different neoplasias.
|
20073996 |
2010 |
Neoplasms
|
0.100 |
AlteredExpression
|
group |
BEFREE |
Significantly higher CYP2E1 expression was associated with an invasive lobular type of tumor, locally advanced disease as well as with non-tumor tissue of progesterone receptor-negative patients.
|
18214058 |
2008 |
Neoplasms
|
0.100 |
GeneticVariation
|
group |
BEFREE |
Vinyl chloride (VC) is a human carcinogen known to undergo metabolism by cytochrome P450 2E1 (CYP2E1) to reactive intermediates that can cause oncogene and tumor suppressor gene mutations and that are further metabolized by acetaldehyde dehydrogenase (ALDH2) and glutathione-S-transferases (GSTs) to non-mutagenic end products.
|
17384900 |
2007 |
Neoplasms
|
0.100 |
AlteredExpression
|
group |
BEFREE |
The expression frequency of CYP1A1 and CYP2E1 in tumors is independent of their genetic polymorphism.
|
17127240 |
2007 |
Neoplasms
|
0.100 |
GeneticVariation
|
group |
BEFREE |
The results of the present study suggest that the CYP2E1 c2/c2 genotype increases susceptibility to rectal cancer and the gene-environmental interactions between the CYP2E1 polymorphism and smoking or alcohol drinking exist for colorectal neoplasia in general.
|
17963298 |
2007 |
Neoplasms
|
0.100 |
AlteredExpression
|
group |
BEFREE |
Chronic ethanol consumption may promote carcinogenesis by (1) production of acetaldehyde, which is a weak mutagen and carcinogen; (2) induction of cytochrome P450 2E1 and associated oxidative stress and conversion of procarcinogens to carcinogens; (3) depletion of S-adenosylmethionine and, consequently, induction of global DNA hypomethylation; (4) induction of increased production of inhibitory guanine nucleotide regulatory proteins and components of extracellular signal-regulated kinase-mitogen-activated protein kinase signaling; (5) accumulation of iron and associated oxidative stress; (6) inactivation of the tumor suppressor gene BRCA1 and increased estrogen responsiveness (primarily in breast); and (7) impairment of retinoic acid metabolism.
|
16054976 |
2005 |
Neoplasms
|
0.100 |
GeneticVariation
|
group |
BEFREE |
Analyzing a correlation between certain neoplasia and alteration of the CYP2E1 gene, most studies focus on the polymorphisms -1053C>T and 7632T>A, but recently another polymorphism, named -71G>T, with enhanced transcriptional activity, has been identified.
|
15177663 |
2004 |
Neoplasms
|
0.100 |
GeneticVariation
|
group |
BEFREE |
The CYP2E1 variant genotype did not significantly increase the risk for neoplasia.
|
12552594 |
2003 |
Neoplasms
|
0.100 |
GeneticVariation
|
group |
BEFREE |
No statistically significant changes were observed when the CYP2E1 genotype was examined relative to tumor differentiation and smoking status.
|
12115524 |
2002 |
Neoplasms
|
0.100 |
GeneticVariation
|
group |
BEFREE |
To establish the distribution of CYP2E1 RsaI polymorphism in patients with hepatocellular carcinoma and to evaluate its possible role in the multifactorial pathogenesis of this tumour.
|
8977352 |
1996 |
Neoplasms
|
0.100 |
GeneticVariation
|
group |
BEFREE |
To investigate the possible role of CYP2E1 genetic polymorphisms in the etiology of this tumor, we investigated 50 histologically confirmed NPC cases from Taiwan and 50 controls matched to cases on age, sex, and residence.
|
8547826 |
1995 |
Neoplasms
|
0.100 |
Biomarker
|
group |
BEFREE |
We have demonstrated the presence of CYP2E1 protein in a catalytically active form in lung tumors, differences being observed between the tumors and normal tissues from the same patients.
|
7802636 |
1994 |